Provided by Tiger Trade Technology Pte. Ltd.

Haemonetics

59.34
-5.6800-8.74%
Post-market: 59.10-0.2400-0.40%19:39 EST
Volume:2.02M
Turnover:122.56M
Market Cap:2.76B
PE:16.35
High:66.09
Open:65.19
Low:59.04
Close:65.02
52wk High:87.32
52wk Low:47.32
Shares:46.47M
Float Shares:46.47M
Volume Ratio:1.78
T/O Rate:4.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.63
EPS(LYR):3.31
ROE:19.47%
ROA:6.36%
PB:3.25
PE(LYR):17.93

Loading ...

These Analysts Revise Their Forecasts On Haemonetics After Q3 Earnings

Benzinga
·
13 hours ago

Stock Track | Haemonetics Plummets 5.04% Intraday Following Series of Analyst Price Target Cuts

Stock Track
·
Yesterday

Haemonetics price target lowered to $81 from $99 at Baird

TIPRANKS
·
Yesterday

Haemonetics Is Maintained at Outperform by Barrington Research

Dow Jones
·
Yesterday

Haemonetics price target lowered to $75 from $88 at Citi

TIPRANKS
·
Yesterday

Haemonetics Price Target Maintained With a $88.00/Share by BTIG

Dow Jones
·
Yesterday

Orchestra Biomed Unveils Vision for Growth With Updates on Pivotal Cardiovascular Trials and Strategic Partnerships

Reuters
·
Yesterday

Earnings Flash (HAE) Haemonetics Posts Fiscal Q3 Adjusted EPS $1.31, vs. FactSet Est of $1.22

MT Newswires Live
·
Feb 05

Haemonetics Outlook FY Organic Growth 0-2%

THOMSON REUTERS
·
Feb 05

Haemonetics Q3 Adjusted EPS USD 1.31 VS. Ibes Estimate USD 1.25

THOMSON REUTERS
·
Feb 05

GUIDANCE:(HAE) Haemonetics Expects Fiscal 2026 Adjusted EPS Range $4.90 - $5, vs. FactSet Est of $4.70

MT Newswires Live
·
Feb 05

Haemonetics Q3 Adj. EPS $1.31 Beats $1.25 Estimate, Sales $338.967M Beat $331.616M Estimate

Benzinga
·
Feb 05

Haemonetics posts Q3 adjusted earnings per share of USD 1.31, up 10%

Reuters
·
Feb 05

Haemonetics meldet für das dritte Quartal einen Umsatz von 56,6 Mio. USD, ein Rückgang um 19,6 Prozent

Reuters
·
Feb 05

Haemonetics meldet Free Cash Flow im dritten Quartal 2026 von 165,42 Mio. USD mit Anstieg um 233 Prozent

Reuters
·
Feb 05

Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Release

Reuters
·
Feb 05

Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

THOMSON REUTERS
·
Feb 05

Haemonetics (HAE) Receives a Buy from Barrington

TIPRANKS
·
Feb 02

Haemonetics Is Maintained at Outperform by Barrington Research

Dow Jones
·
Feb 02

Earning Preview: Haemonetics — this quarter’s revenue is expected to increase by 1.31%, and institutional views are positive

Earnings Agent
·
Jan 29